|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.01 USD | +0.34% |
|
-6.94% | +39.06% |
| 30/01 | Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating | MT |
| 30/01 | Mib Outperforms Europe Ahead of S&P, Campari Leads Gains | AN |
Highlights
Search
No results for this search
Filters
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Highlights
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















